3,4-dihydroxyphenylacetic acid has been researched along with Dystonia in 5 studies
3,4-Dihydroxyphenylacetic Acid: A deaminated metabolite of LEVODOPA.
(3,4-dihydroxyphenyl)acetic acid : A dihydroxyphenylacetic acid having the two hydroxy substituents located at the 3- and 4-positions. It is a metabolite of dopamine.
dihydroxyphenylacetic acid : A dihydroxy monocarboxylic acid consisting of phenylacetic acid having two phenolic hydroxy substituents.
Dystonia: An attitude or posture due to the co-contraction of agonists and antagonist muscles in one region of the body. It most often affects the large axial muscles of the trunk and limb girdles. Conditions which feature persistent or recurrent episodes of dystonia as a primary manifestation of disease are referred to as DYSTONIC DISORDERS. (Adams et al., Principles of Neurology, 6th ed, p77)
Excerpt | Relevance | Reference |
---|---|---|
"Two cases of severe dystonia and dyskinesia were treated with talipexole, a dopamine autoreceptor agonist, and the metabolites of dopamine, norepinephrine, and serotonin in cerebrospinal fluid (CSF) were determined." | 3.68 | Chronic treatment with talipexole dihydrochloride on abnormal involuntary movement in humans. ( Koga, I; Nishikawa, T; Tanaka, M; Tsuda, A; Uchida, Y; Yamada, S, 1990) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (40.00) | 18.7374 |
1990's | 1 (20.00) | 18.2507 |
2000's | 2 (40.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Augood, SJ | 1 |
Hollingsworth, Z | 1 |
Albers, DS | 1 |
Yang, L | 1 |
Leung, J | 1 |
Breakefield, XO | 1 |
Standaert, DG | 1 |
Dang, MT | 1 |
Yokoi, F | 1 |
McNaught, KS | 1 |
Jengelley, TA | 1 |
Jackson, T | 1 |
Li, J | 1 |
Li, Y | 1 |
Rotrosen, J | 1 |
Stanley, M | 1 |
Kuhn, C | 1 |
Wazer, D | 1 |
Gershon, S | 1 |
Nishikawa, T | 1 |
Yamada, S | 1 |
Tsuda, A | 1 |
Tanaka, M | 1 |
Koga, I | 1 |
Uchida, Y | 1 |
Stahl, SM | 1 |
Faull, KF | 1 |
Barchas, JD | 1 |
Berger, PA | 1 |
5 other studies available for 3,4-dihydroxyphenylacetic acid and Dystonia
Article | Year |
---|---|
Dopamine transmission in DYT1 dystonia.
Topics: 3,4-Dihydroxyphenylacetic Acid; Autoradiography; Basal Ganglia; Benzamides; Benzazepines; Binding Si | 2004 |
Generation and characterization of Dyt1 DeltaGAG knock-in mouse as a model for early-onset dystonia.
Topics: 3,4-Dihydroxyphenylacetic Acid; Age of Onset; Animals; Brain; Chromatography, High Pressure Liquid; | 2005 |
Experimental dystonia induced by quaternary-chlorpromazine.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Behavior, Animal; Chlorpromazine; Corpus Striatum; Disease | 1980 |
Chronic treatment with talipexole dihydrochloride on abnormal involuntary movement in humans.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aged; Azepines; Dopamine Agents; Dystonia; Homovanillic Acid; Humans | 1990 |
CSF monamine metabolites in movement disorders and normal aging.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adult; Aged; Dyskinesia, Drug-Induced; Dystonia; Female; Glycols; Ho | 1985 |